Symptom-centric view

Acne

Substances reporting Acne disproportionately — ranked by ROR.

Pain Drug ineffective Off label use Fatigue Dyspnoea Acute kidney injury

showing 45 of 45

Substance ↓	ROR [95% CI]	Reports	Category	Label
vandetanib —	15.4 [12.5–19.0]	95	algemeen	new
upadacitinib —	5.1 [4.9–5.4]	1,409	algemeen	new
triptorelin —	3.6 [2.8–4.5]	73	algemeen	new
tretinoin Retin-A · Atralin	6.4 [5.6–7.4]	198	injectables	new
trametinib —	2.9 [2.6–3.3]	250	algemeen	new
titanium dioxide(nano) —	21.3 [11.2–40.5]	10	algemeen	new
titanium dioxide —	10.5 [6.0–18.3]	13	algemeen	new
testosterone undecanoate —	3.1 [2.0–4.8]	21	algemeen	new
tazarotene —	8.8 [6.5–12.0]	42	algemeen	new
sulfur —	49.2 [47.0–51.5]	2,277	algemeen	new
sulfacetamide sodium, sulfur —	7.4 [2.3–23.1]	3	algemeen	new
sodium sulfacetamide —	6.8 [2.8–16.4]	5	algemeen	new
skin barrier sun shield spf 30 —	21.3 [11.2–40.5]	10	algemeen	new
salicylic acid —	93.0 [91.0–95.1]	11,761	algemeen	new
panitumumab —	5.6 [5.0–6.3]	299	algemeen	new
norgestrel —	7.9 [6.2–10.2]	63	algemeen	new
norgestimate and ethinyl estradiol —	3.9 [3.1–5.0]	64	algemeen	new
norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate —	3.9 [2.9–5.3]	45	algemeen	new
norethindrone acetate and ethinyl estradiol —	3.6 [3.0–4.5]	93	algemeen	new
neomycin, polymyxin b, pramoxine hcl —	5.5 [3.9–7.9]	32	algemeen	new
moisturizer —	31.2 [18.0–54.3]	14	algemeen	new
medicated hemorrhoidal wipes —	17.0 [6.9–42.0]	5	algemeen	new
levonorgestrel —	2.9 [2.8–3.0]	2,133	algemeen	new
japanese sunscreen spf 50 super water gel sunscreen 4.22floz(125g) refill —	21.3 [11.2–40.5]	10	algemeen	new
isotretinoin —	5.4 [5.1–5.8]	929	algemeen	new
homosalate, octinoxate, octisalate, oxybenzone —	21.3 [11.2–40.5]	10	algemeen	new
gefitinib —	3.2 [2.7–3.9]	105	algemeen	new
fluocinolone acetonide, hydroquinone, and tretinoin —	4.1 [2.0–8.2]	8	algemeen	new
everyday skin tint spf 30 —	21.3 [11.2–40.5]	10	algemeen	new
elexacaftor, tezacaftor, and ivacaftor —	3.5 [3.0–4.1]	155	algemeen	new
drospirenone —	3.1 [2.9–3.4]	584	algemeen	new
clindamycin phosphate topical —	3.8 [2.8–5.0]	46	algemeen	new
cetuximab —	2.9 [2.6–3.3]	327	algemeen	new
bimekizumab —	3.4 [2.9–3.9]	196	algemeen	new
benzoyl peroxide —	69.0 [65.3–73.0]	1,571	algemeen	new
bacitracin zinc, polymyxin b sulfate —	5.8 [4.1–8.3]	32	algemeen	new
bacitracin zinc, neomycin, polymyxin b —	5.6 [3.9–7.9]	32	algemeen	new
bacitracin zinc, neomycin sulfate, polymyxin b sulfate —	5.5 [3.8–7.8]	32	algemeen	new
avobenzone, homosalate,otisalate, octocrylene —	21.3 [11.2–40.5]	10	algemeen	new
avobenzone, homosalate, octocrylene, octisalate —	20.2 [10.6–38.3]	10	algemeen	new
avobenzone, homosalate, octisalate, octocrylene —	4.3 [2.3–8.0]	10	algemeen	new
avobenzone, homosalate, octisalate —	4.0 [2.2–7.3]	11	algemeen	new
avobenzone, homosalate, octisalat, octocrylene —	21.3 [11.2–40.5]	10	algemeen	new
afatinib —	7.2 [6.2–8.4]	168	algemeen	new
adapalene —	159.9 [157.5–162.4]	39,471	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).